SWOG clinical trial number

PREADVISE, Prevention of Alzheimer's Disease with Vitamin E and Selenium, Phase III Ancillary to S0000 - SELECT

Abbreviated Title
Institutions listed in protocol Appendix 19.5


Selenium Vitamin E

Eligibility Criteria Expand/Collapse

Only SELECT participants may be considered for this study

Publication Information Expand/Collapse


Mental Component score (MCS) from Health-related Quality of Life Predicts Incidence of Dementia in U.S. Males

X Ding;E Abner;F Schmitt;J Crowley;P Goodman;R Kryscio Journal of Prevention of Alzheimer's Disease 8(2):169-174

PMid: PMID33569563 | PMC number: PMC8162937


Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE)

R Kryscio;EL Abner;A Caban-Holt;M Lovell;P Goodman;J Hartline;A Darke;M Yee;J Crowley;FA Schmitt JAMA Neurology May 1;74(5):567-573

PMid: PMID28319243 | PMC number: PMC5506489

Diabetes mitigates the role of memory complaint in predicting dementia risk: Results from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Study

X Zhang;F Schmitt;A Caban-Holt;X Ding;RJ Kryscio;E Abner Journal of Prevention of Alzheimer’s Disease 4(3):143-148. Epub 2017 Mar 7

PMid: PMID28944218 | PMC number: PMC5607951


Self-reported sleep apnea and dementia risk: Findings from The Prevention of Alzheimer’s Disease with Vitamin E and Selenium Trial

X Ding;RJ Kryscio;JK Turner;GA Jicha;GE Cooper;A Caban-Holt;F Schmitt;E Abner Journal of the American Geriatrics Society Dec;64(12):2472-2478; 2016 Nov 1[Epub ahead of print]

PMid: PMID27801937 | PMC number: PMC5173398


Baseline subjective memory complaints associate with increased risk of incident dementia: The PREADVISE Trial

EL Abner;RJ Kryscio;A Caban-Holt;FA Schmitt Journal of Prevention of Alzheimers Disease 2(1):11-16

PMid: PMID26180776 | PMC number: PMC4500536


Normal young-old men: Results from PREADVISE

E Abner;R Kryscio;A Caban-Holt;F Schmitt The Journal of Prevention of Alzheimer’s Disease 1(3): 259-60, 2014; Clinical Trials Conf. on Alzheimer’s Disease (Nov. 20-22, 2014, Phil., PA), poster

Lower quality of life scores at baseline are associated with an increased risk of future cognitive impairment: Results from PREADVISE

R Kryscio;A Abner;A Caban-Holt;FA Schmitt The Journal of Prevention of Alzheimer’s Disease, 1(3):283; 2014;Clinical Trials Conf. on Alzheimer’s Disease (November 20-22, 2014, Phil., PA), poster


A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE trial

RJ Kryscio;EL Abner;FA Schmitt;P Goodman;M Mendiondo;A Caban-Holt;BC Dennis;EA Klein;JJ Crowley Journal of Nutrition, Health and Aging 17(1):72-75;

PMid: PMID23299383 | PMC number: PMC2329983


Age expanded normative data for the Ruff 2 & 7 Selective Attention Test: evaluating cognition in older males

A Caban-Holt;E Abner;RJ Kryscio;J Crowley;FA Schmitt The Clinical Neuropsychologist 26(5):751-768

PMid: PMID22651854 | PMC number: PMC23064404

Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial

EL Abner;BC Dennis;MJ Mathews;MS Mendiondo;A Caban-Holt;RJ Kryscio;FA Schmitt;J Crowley Trials 13(1):217

PMid: PMID23171483 | PMC number: PMC3543284


Studying the effects of vitamin E and selenium for Alzheimer's disease prevention: The PREADVISE model

AM Caban-Holt;FA Schmitt;CR Runyons;RJ Kryscio;MS Mendiondo;MS Healey;WR Markesbery;CA Coltman;JJ Crowley;PJ Goodman;JL Hartline In: Research and Practice in Alzheimer's Disease Volume 11. B Vellas, eds. Serdi Publishers 124-130